New Frontiers in Diabetes Care
Status Publisher Jazyk angličtina Země Spojené státy americké Médium print-electronic
Typ dokumentu dopisy
Grantová podpora
00064203
Ministerstvo Zdravotnictví Ceské Republiky
PubMed
37256528
DOI
10.1007/s11606-023-08251-y
PII: 10.1007/s11606-023-08251-y
Knihovny.cz E-zdroje
Zobrazit více v PubMed
Tanumihardjo JP, Kuther S, Wan W, et al. New Frontiers in Diabetes Care: Quality Improvement Study of a Population Health Team in Rural Critical Access Hospitals. J Gen Intern Med. 202; 2:1–9. doi: https://doi.org/10.1007/s11606-022-07928-0 . DOI
Brož J, Janíčková Žďárská D, Urbanová J, et al. Current Level of Glycemic Control and Clinical Inertia in Subjects Using Insulin for the Treatment of Type 1 and Type 2 Diabetes in the Czech Republic and the Slovak Republic: Results of a Multinational, Multicenter, Observational Survey (DIAINFORM). Diabetes Ther. 2018;9(5):1897-1906. doi: https://doi.org/10.1007/s13300-018-0485-2 . PubMed DOI PMC
Reach G, Pechtner V, Gentilella R, Corcos A, Ceriello A. Clinical inertia and its impact on treatment intensification in people with type 2 diabetes mellitus. Diabetes Metab. 2017;43(6):501–11. https://doi.org/10.1016/j.diabet.2017.06.0033 . PubMed DOI
Pablos-Velasco P, Parhofer KG, Bradley C, et al. Current level of glycaemic control and its associated factors in patients with type 2 diabetes across Europe: data from the PANORAMA study. Clin Endocrinol. 2014;80:47–56. DOI
Selvin E, Parrinello ChM, Daya N, Bergenstal RM. Trends in insulin use and diabetes control in the US: 1988–1994 and 1999–2012. Diabetes Care. 2016;39(3):e33–e35. doi: https://doi.org/10.2337/dc15-2229 . PubMed DOI
